Form 4: Esperion Therapeutics: Insider Sells Shares for Tax Obligations
Statement of Changes in Beneficial Ownership
Benjamin Looker, Chief Legal Officer at Esperion Therapeutics, sold 11,824 shares of common stock on June 17, 2026, to cover tax obligations.
Summary
- Benjamin Looker, Chief Legal Officer of Esperion Therapeutics, Inc., reported a transaction on June 17, 2026.
- The transaction involved the sale of 11,824 shares of common stock.
- The sale price was $3.155 per share.
- The reason for the sale was to satisfy tax obligations arising from vested restricted stock units.
- Following the transaction, Looker beneficially owns 667,524 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard insider sale for tax purposes and does not indicate a change in the insider's view of the company's prospects.
Negatives
- Insider selling can sometimes be perceived negatively by the market, although in this case, it was for tax obligations.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and typically reflect personal financial management rather than company performance. The sale of shares to cover tax obligations on vested equity is a common practice among executives.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Benjamin Looker granted a Limited Power of Attorney to Sheldon Koenig and Richard Bartram to execute SEC forms on his behalf. | 12/13/2021 | Facilitates timely and accurate filing of required disclosures by authorized representatives. |
Stakeholder Impact
- Shareholders: The sale is for tax obligations and does not necessarily reflect a negative outlook on the company's stock performance, but insider selling can sometimes create short-term market perception issues.
Key Dates
| Date | Description |
|---|---|
| 12/13/2021 | Date of execution for the Limited Power of Attorney granted by Benjamin Looker. |
| 06/17/2026 | Transaction date for the sale of Esperion Therapeutics common stock by Benjamin Looker. |
| 06/18/2026 | Date of signature for the Form 4 filing, by power of attorney. |
Keywords
Esperion Therapeutics, ESPR, Form 4, Insider Transaction, Stock Sale, Tax Obligation, Chief Legal Officer, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.